{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T18:36:02Z","timestamp":1772390162635,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12325-023-02519-9","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T03:12:17Z","timestamp":1683515537000},"page":"2915-2926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Eliciting Patient Insights on the Burden of Nontuberculous Mycobacterial Lung Disease (NTM-LD) and Healthcare Gaps in Germany Through Qualitative Semi-structured Interviews"],"prefix":"10.1007","volume":"40","author":[{"given":"Christian","family":"Hoenig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roald","family":"van der Laan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Wiesmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Obradovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"issue":"3","key":"2519_CR1","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3978\/j.issn.2072-1439.2013.12.24","volume":"6","author":"MM Johnson","year":"2014","unstructured":"Johnson MM, Odell JA. Nontuberculous mycobacterial pulmonary infections. J Thorac Dis. 2014;6(3):210\u201320. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2013.12.24.","journal-title":"J Thorac Dis"},{"issue":"1","key":"2519_CR2","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/22221751.2019.1637702","volume":"8","author":"Y Matsumoto","year":"2019","unstructured":"Matsumoto Y, Kinjo T, Motooka D, et al. Comprehensive subspecies identification of 175 nontuberculous mycobacteria species based on 7547 genomic profiles. Emerg Microbes Infect. 2019;8(1):1043\u201353. https:\/\/doi.org\/10.1080\/22221751.2019.1637702.","journal-title":"Emerg Microbes Infect"},{"issue":"12","key":"2519_CR3","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/17476348.2017.1386563","volume":"11","author":"LO Larsson","year":"2017","unstructured":"Larsson LO, Polverino E, Hoefsloot W, et al. Pulmonary disease by non-tuberculous mycobacteria\u2014clinical management, unmet needs and future perspectives. Expert Rev Respir Med. 2017;11(12):977\u201389. https:\/\/doi.org\/10.1080\/17476348.2017.1386563.","journal-title":"Expert Rev Respir Med"},{"key":"2519_CR4","doi-asserted-by":"publisher","unstructured":"Floto RA, Olivier KN, Saiman L, et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016;71(Suppl 1):i1\u201322. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-207360.","DOI":"10.1136\/thoraxjnl-2015-207360"},{"issue":"6","key":"2519_CR5","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3201\/eid2206.151642","volume":"22","author":"FC Ringshausen","year":"2016","unstructured":"Ringshausen FC, Wagner D, de Roux A, et al. Prevalence of nontuberculous mycobacterial pulmonary disease, Germany, 2009\u20132014. Emerg Infect Dis. 2016;22(6):1102\u20135. https:\/\/doi.org\/10.3201\/eid2206.151642.","journal-title":"Emerg Infect Dis"},{"key":"2519_CR6","doi-asserted-by":"publisher","unstructured":"Ringshausen FC, Rademacher J. Lungenerkrankung durch nichttuberkul\u00f6se Mykobakterien [Nontuberculous mycobacterial pulmonary disease]. Internist (Berl). 2016;57(2):142\u201352. German. https:\/\/doi.org\/10.1007\/s00108-015-0014-6.","DOI":"10.1007\/s00108-015-0014-6"},{"issue":"1","key":"2519_CR7","doi-asserted-by":"publisher","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","volume":"56","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Eur Respir J. 2020;56(1):2000535. https:\/\/doi.org\/10.1183\/13993003.00535-2020.","journal-title":"Eur Respir J"},{"issue":"4","key":"2519_CR8","doi-asserted-by":"publisher","first-page":"1602109","DOI":"10.1183\/13993003.02109-2016","volume":"49","author":"R Diel","year":"2017","unstructured":"Diel R, Jacob J, Lampenius N, et al. Burden of non-tuberculous mycobacterial pulmonary disease in Germany. Eur Respir J. 2017;49(4):1602109. https:\/\/doi.org\/10.1183\/13993003.02109-2016.","journal-title":"Eur Respir J"},{"issue":"1","key":"2519_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1055\/s-0033-1333569","volume":"34","author":"J van Ingen","year":"2013","unstructured":"van Ingen J. Diagnosis of nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013;34(1):103\u20139. https:\/\/doi.org\/10.1055\/s-0033-1333569.","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"2519_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000591","volume":"7","author":"M Lipman","year":"2020","unstructured":"Lipman M, Cleverley J, Fardon T, et al. Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK. BMJ Open Respir Res. 2020;7(1):e000591. https:\/\/doi.org\/10.1136\/bmjresp-2020-000591.","journal-title":"BMJ Open Respir Res"},{"issue":"7","key":"2519_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/cid\/cix517","volume":"65","author":"N Kwak","year":"2017","unstructured":"Kwak N, Park J, Kim E, Lee CH, Han SK, Yim JJ. Treatment outcomes of Mycobacterium avium complex lung disease: a systematic review and meta-analysis. Clin Infect Dis. 2017;65(7):1077\u201384. https:\/\/doi.org\/10.1093\/cid\/cix517.","journal-title":"Clin Infect Dis"},{"key":"2519_CR12","unstructured":"FDA. FDA patient-focused drug development guidance series for enhancing the incorporation of the patient\u2019s voice in medical product development and regulatory decision making. 2020. https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical. Accessed 18 Nov 2021."},{"key":"2519_CR13","unstructured":"FDA. FDA patient-focused drug development: methods to identify what is important to patients. Guidance for industry, Food and Drug Administration staff, and other stakeholders. DRAFT GUIDANCE. 2019. https:\/\/www.fda.gov\/media\/131230\/download. Accessed 18 Nov 2021."},{"key":"2519_CR14","doi-asserted-by":"publisher","unstructured":"van Ingen J, Wagner D, Gallagher J, et al. Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases. Eur Respir J. 2017;49(2):1601855. https:\/\/doi.org\/10.1183\/13993003.01855-2016.","DOI":"10.1183\/13993003.01855-2016"},{"key":"2519_CR15","unstructured":"Bildungsstand: Verteilung der Bev\u00f6lkerung in Deutschland nach h\u00f6chstem Schulabschluss. 2018. https:\/\/de.statista.com\/statistik\/daten\/studie\/1988\/umfrage\/bildungsabschluesse-in-deutschland\/. Accessed 18 Nov 2021."},{"key":"2519_CR16","unstructured":"British Lung Foundation. My COPD and NTM symptoms are very similar. 2019. https:\/\/www.blf.org.uk\/your-stories\/my-symptoms-from-copd-and-ntm-are-very-similar. Accessed 18 Nov 2021."},{"key":"2519_CR17","unstructured":"British Lung Foundation. I discovered I had NTM by accident. 2019. https:\/\/www.blf.org.uk\/your-stories\/i-discovered-i-had-ntm-by-accident. Accessed 18 Nov 2021."},{"issue":"Suppl. 64","key":"2519_CR18","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1183\/13993003.congress-2020.3338","volume":"56","author":"M Shteinberg","year":"2020","unstructured":"Shteinberg M, Boyd J, Harris B, et al. What\u2019s important for people with NTM? An EMBARC-ELF patient survey. Eur Respir J. 2020;56(Suppl. 64):3338. https:\/\/doi.org\/10.1183\/13993003.congress-2020.3338.","journal-title":"Eur Respir J"},{"issue":"6","key":"2519_CR19","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.21037\/jtd-20-803","volume":"12","author":"Y Hachisu","year":"2020","unstructured":"Hachisu Y, Murata K, Takei K, et al. Prognostic nutritional index as a predictor of mortality in nontuberculous mycobacterial lung disease. J Thorac Dis. 2020;12(6):3101\u20139. https:\/\/doi.org\/10.21037\/jtd-20-803.","journal-title":"J Thorac Dis"},{"issue":"5","key":"2519_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2169\/internalmedicine.53.1277","volume":"53","author":"K Morimoto","year":"2014","unstructured":"Morimoto K, Yoshiyama T, Kurashima A, et al. Nutritional indicators are correlated with the radiological severity score in patients with Mycobacterium avium complex pulmonary disease: a cross-sectional study. Intern Med. 2014;53(5):397\u2013401. https:\/\/doi.org\/10.2169\/internalmedicine.53.1277.","journal-title":"Intern Med"},{"key":"2519_CR21","doi-asserted-by":"publisher","unstructured":"Wagner D, van Ingen J, van der Laan R, Obradovic M, NTM-NET. Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey. BMJ Open Respir Res. 2020;7(1):e000498. https:\/\/doi.org\/10.1136\/bmjresp-2019-000498. (Erratum in: BMJ Open Respir Res. 2020 Jun;7(1): PMID: 32332023; PMCID: PMC7204844).","DOI":"10.1136\/bmjresp-2019-000498"},{"issue":"3","key":"2519_CR22","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","volume":"50","author":"E Polverino","year":"2017","unstructured":"Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629. https:\/\/doi.org\/10.1183\/13993003.00629-2017.","journal-title":"Eur Respir J"},{"issue":"Suppl 2","key":"2519_CR23","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","volume":"72","author":"CS Haworth","year":"2017","unstructured":"Haworth CS, Banks J, Capstick T, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72(Suppl 2):ii1\u201364. https:\/\/doi.org\/10.1136\/thoraxjnl-2017-210927.","journal-title":"Thorax"},{"key":"2519_CR24","doi-asserted-by":"publisher","first-page":"100178","DOI":"10.1016\/j.jctube.2020.100178","volume":"20","author":"R Diel","year":"2020","unstructured":"Diel R, Obradovic M, Tyler S, Engelhard J, Kostev K. Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in general and pneumologist practices in Germany. J Clin Tuberc Other Mycobact Dis. 2020;20:100178. https:\/\/doi.org\/10.1016\/j.jctube.2020.100178.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"2519_CR25","unstructured":"von Bandemer S, Salewski K, Schwanitz R. Integrative Versorgungskonzepte bei seltenen Erkrankungen: Der Ansatz von Shared Care. Forschung Aktuell. 2010; 03\/2010 [about 9 p.]. http:\/\/nbn-resolving.de\/urn:nbn:de:0176-201003017. Accessed 18 Nov 2021."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02519-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02519-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02519-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T04:36:08Z","timestamp":1685075768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02519-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["2519"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02519-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,8]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}